228 related articles for article (PubMed ID: 22126708)
1. Evidence-based pharmacological treatment of substance use disorders and pathological gambling.
van den Brink W
Curr Drug Abuse Rev; 2012 Mar; 5(1):3-31. PubMed ID: 22126708
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapies for adolescent substance use disorders.
Simkin DR; Grenoble S
Child Adolesc Psychiatr Clin N Am; 2010 Jul; 19(3):591-608. PubMed ID: 20682223
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for Substance Use Disorders.
Klein JW
Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620
[TBL] [Abstract][Full Text] [Related]
4. Clinical uses of naltrexone: a review of the evidence.
Modesto-Lowe V; Van Kirk J
Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
[TBL] [Abstract][Full Text] [Related]
5. [Levels of evidence in drug therapy for alcohol use disorders and illicit drug use].
Burucker J; Kropp S
Fortschr Neurol Psychiatr; 2012 Dec; 80(12):684-93. PubMed ID: 23229101
[TBL] [Abstract][Full Text] [Related]
6. Medications for substance use disorders.
Douaihy AB; Kelly TM; Sullivan C
Soc Work Public Health; 2013; 28(3-4):264-78. PubMed ID: 23731419
[TBL] [Abstract][Full Text] [Related]
7. Rational development of addiction pharmacotherapies: successes, failures, and prospects.
Pierce RC; O'Brien CP; Kenny PJ; Vanderschuren LJ
Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a012880. PubMed ID: 22675669
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic treatments for drug and alcohol dependence.
Kranzler HR; Amin H; Modesto-Lowe V; Oncken C
Psychiatr Clin North Am; 1999 Jun; 22(2):401-23. PubMed ID: 10385941
[TBL] [Abstract][Full Text] [Related]
9. Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving.
Heidbreder CA; Hagan JJ
Curr Opin Pharmacol; 2005 Feb; 5(1):107-18. PubMed ID: 15661634
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of dual substance abuse and dependence.
Kenna GA; Nielsen DM; Mello P; Schiesl A; Swift RM
CNS Drugs; 2007; 21(3):213-37. PubMed ID: 17338593
[TBL] [Abstract][Full Text] [Related]
11. The Persistent Challenge of Developing Addiction Pharmacotherapies.
Swinford-Jackson SE; O'Brien CP; Kenny PJ; Vanderschuren LJMJ; Unterwald EM; Pierce RC
Cold Spring Harb Perspect Med; 2021 Nov; 11(11):. PubMed ID: 32601131
[TBL] [Abstract][Full Text] [Related]
12. [Topiramate in substance-related and addictive disorders].
Cohen J; Dervaux A; Laqueille X
Presse Med; 2014 Sep; 43(9):892-901. PubMed ID: 25027463
[TBL] [Abstract][Full Text] [Related]
13. New horizons for therapeutics in drug and alcohol abuse.
Jupp B; Lawrence AJ
Pharmacol Ther; 2010 Jan; 125(1):138-68. PubMed ID: 19917308
[TBL] [Abstract][Full Text] [Related]
14. Addiction pharmacotherapy 2000: new options, new challenges.
Rawson RA; McCann MJ; Hasson AJ; Ling W
J Psychoactive Drugs; 2000; 32(4):371-8. PubMed ID: 11210198
[TBL] [Abstract][Full Text] [Related]
15. Current pharmacotherapy for gambling disorder: a systematic review.
Kraus SW; Etuk R; Potenza MN
Expert Opin Pharmacother; 2020 Feb; 21(3):287-296. PubMed ID: 31928246
[No Abstract] [Full Text] [Related]
16. Current concepts in pharmacotherapy of substance abuse.
Gottschalk PC; Jacobsen LK; Kosten TR
Curr Psychiatry Rep; 1999 Dec; 1(2):172-8. PubMed ID: 11122921
[TBL] [Abstract][Full Text] [Related]
17. Treatment of patients with substance use disorders, second edition. American Psychiatric Association.
Kleber HD; Weiss RD; Anton RF; George TP; Greenfield SF; Kosten TR; O'Brien CP; Rounsaville BJ; Strain EC; Ziedonis DM; Hennessy G; Connery HS; McIntyre JS; Charles SC; Anzia DJ; Cook IA; Finnerty MT; Johnson BR; Nininger JE; Summergrad P; Woods SM; Yager J; Pyles R; Cross CD; Peele R; Shemo JP; Lurie L; Walker RD; Barnovitz MA; Gray SH; Saxena S; Tonnu T; Kunkle R; Albert AB; Fochtmann LJ; Hart C; Regier D; ; ;
Am J Psychiatry; 2007 Apr; 164(4 Suppl):5-123. PubMed ID: 17569411
[No Abstract] [Full Text] [Related]
18. How treatments for pathological gambling can be informed by treatments for substance use disorders.
Petry NM
Exp Clin Psychopharmacol; 2002 Aug; 10(3):184-92. PubMed ID: 12233980
[TBL] [Abstract][Full Text] [Related]
19. Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.
Soyka M; Rösner S
Curr Drug Abuse Rev; 2008 Nov; 1(3):280-91. PubMed ID: 19630726
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic management of relapse prevention in addictive disorders.
Sofuoglu M; Kosten TR
Psychiatr Clin North Am; 2004 Dec; 27(4):627-48. PubMed ID: 15550284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
